Rayont Inc (RAYT) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Rayont Inc   (RAYT)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Rayont Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Rayont Inc's ROI in the third quarter of 2023?
Rayont Inc achieved a return on average invested assets (ROI) of 9.73 % in its third quarter of 2023, this is above RAYT's average return on investment of -9201.86%.
Rayont Inc invested over the 12 months ending in its third quarter of 2023 $7 million

ROI fell compared to the second quarter of 2023, despite the net income growth of % from the second quarter of 2023.

Within the Healthcare sector 99 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2023 from 501 to 950.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2023)
III. Quarter		 (Dec 31 2022)
II. Quarter		 (Sep 30 2022)
I. Quarter		 (Jun 30 2022)
IV. Quarter		 (Mar 31 2022)
III. Quarter
Y / Y Investment Change TTM 46.06 % 43.54 % 44.3 % 68.7 % 143.13 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 6 7 7 10 5
Return On Investment (TTM) 9.73 % 15.27 % 15.73 % 4.09 % -15.21 %
RAYT's Overall Ranking # 950 # 501 # 598 # 0 # 0
Seq. Investment Change TTM 5.17 % 7.74 % 7.65 % 19.73 % 3.36 %
Seq. Net Income Change TTM -32.99 % 4.59 % 313.9 % - -
Net Income (TTM) in Millions 1 1 1 0 -1

RAYT Company Profile >> Back to RAYT Roi Comparisons >> See Annual RAYT Return On Investment



Return On Investment RAYT's Ranking
Within: No.
Industry # 3
Sector # 100
Overall # 950

Return On Investment Statistics
High Average Low
15.25 %
-9201.86 %
-183169.94 %
(Sep 30 2022)   (Mar 31 2018)







Financial Statements
Rayont Inc's III. Quarter Investments $ 6 Millions RAYT's Balance sheet
Rayont Inc's III. Quarter Income $ 0 Millions Quarterly RAYT's Income Statement
RAYT's Income by Division See RAYT's Income by Division


RAYT Annual Return On Investment (Jun 30 2022)
2022		 (Jun 30 2021)
2021		 (Sep 30 2020)
2020		 (Sep 30 2019)
2019		 (Sep 30 2018)
2018
Total Investments in Millions 10 6 1 1 0
Y / Y Investment Growth 66.18 % 546.15 % -6.45 % - -
Net Income in Millions 0 0 0 -1 0
Y / Y Net Income Growth -36.22 % - - - -
Annual Return On Investment 2.47 % 6.44 % -24.87 % -128.04 % -


Annual Roi Comment
In the fiscal year 2022 ROI decreased relative to the previous year to 2.47 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RAYT's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RAYT's Competitors
Subscribers only: Roi for Rayont Inc's Suppliers
Subscribers only: Return On Investment for RAYT's Customers

Other Ratios
RAYT's Roa RAYT's Inventory Turnover Ratio RAYT's Growth Rates RAYT's Dividend Statistics
RAYT's Profitability Ratios RAYT's Asset Turnover Ratio RAYT's Dividend Growth
RAYT's Roe RAYT's Valuation Ratios RAYT's Financial Strength Ratios RAYT's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2023, within Healthcare Sector ROI
Point Biopharma Global Inc   26.11 %
Moderna Inc   23.91 %
Vertex Pharmaceuticals Inc  22.30 %
Siga Technologies Inc  20.24 %
Innoviva Inc   20.18 %
Pro dex Inc   19.98 %
Chemed Corporation  19.95 %
Edwards Lifesciences Corporation  19.78 %
Corcept Therapeutics Inc  19.07 %
Dr Reddy s Laboratories Limited  19.07 %
Iradimed Corporation  19.01 %
Waters Corporation  18.98 %
Pfizer Inc  18.88 %
West Pharmaceutical Services Inc   18.49 %
Zynex inc   18.06 %
Zoetis Inc   17.90 %
Eli Lilly And Company  17.80 %
Ironwood Pharmaceuticals inc   17.58 %
Tenax Therapeutics Inc   17.51 %
Resmed Inc   17.16 %
Regeneron Pharmaceuticals Inc   16.93 %
Merck and Co Inc   16.68 %
Omeros Corporation  16.14 %
Agilent Technologies inc   15.42 %
3m Company  15.00 %
Amgen Inc   14.94 %
Utah Medical Products Inc  14.76 %
Biogen Inc   14.71 %
Amphastar Pharmaceuticals Inc   14.56 %
Carlisle Companies Incorporated  14.08 %

Date modified: 2026-09-08T15:10:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.